Regeneron Pharmaceuticals logo

REGN Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Healthcare Biotechnology SIC: Unknown CIK: 872589 

Login to follow REGN

Transaction DateRecipientSharesTypePriceValue
Jodie Insights Rating